Showing 1401-1410 of 2656 results for "".
- Euclid Systems Announces Expansion of Leadership Teamhttps://modernod.com/news/euclid-systems-announces-expansion-of-leadership-team/2478845/Euclid Systems has announced expansion of its leadership team. Joseph Boorady, OD, FAAO, appointed to the position of president and chief executive officer in January 2020, brings over 25 years of experience in the ophthalmic industry as an eye care professional, educational leader, entrepreneur
- Medical Optometry America to Open First Practice Location in Southcentral Pennsylvaniahttps://modernod.com/news/medical-optometry-america-to-open-first-practice-location-in-southcentral-pennsylvania/2478237/Medical Optometry America (MOA) announced their first practice location will open in Shrewsbury, Pennsylvania in late 2020 and will be led by MOA’s Regional Clinical Director Leslie O’Dell, OD, FAAO. As the first national optometric brand focused exclusively on medical eye care, MOA is lau
- American Academy of Optometry Foundation Announces 2019 Fredric Rosemore Low Vision Educational Grant Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-2019-fredric-rosemore-low-vision-educational-grant-recipient/2476860/The American Academy of Optometry Foundation (AAOF), in collaboration with the Fredric and Marion Rosemore Family Foundation, has announced that So-Yeon Sharon Lee, OD, FAAO, Dipl-ABO, was named the 2019 recipient of the Fredric Rosemore Low Vision Educational Grant. Dr. Lee is an Assistan
- Early Study Shows J&J’s One-Dose COVID-19 Vaccine Triggered Antibodies in all Participantshttps://modernod.com/news/early-study-shows-jjs-one-dose-covid-19-vaccine-triggered-antibodies-in-all-participants/2478759/Detailed phase 1/2a study findings published in the NEJM on Wednesday showed that all volunteers given Johnson & Johnson’s single-dose coronavirus vaccine Ad26.COV2.S had detectable neutralizing antibodies by day 57. In September, the company reported a preview of the interim results in
- MHRA Advises Against Use of Pfizer, BioNTech’s COVID-19 Vaccine in Those With “Significant History” of Allergic Reactionshttps://modernod.com/news/mhra-advises-against-use-of-pfizer-biontechs-covid-19-vaccine-in-those-with-significant-history-of-allergic-reactions/2478646/The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Wednesday warned that people who have a “significant history” of allergic reactions should not receive Pfizer and BioNTech’s COVID-19 vaccine BNT162b2. The regulator issued the alert because two NHS wor
- NASA Astronauts to Headline Heidelberg Engineering’s 2025 International Spectralis Symposiumhttps://modernod.com/news/nasa-astronauts-to-headline-heidelberg-engineerings-2025-international-spectralis-symposium/2482818/Heidelberg Engineering announced that NASA astronauts Warren Hoburg and Tyson Brunstetter, OD, PhD, will lead the keynote presentation at the company’s
- Kala Receives FDA Fast Track Designation for Human MSC-S Therapy for Persistent Corneal Epithelial Defecthttps://modernod.com/news/kala-pharmaceuticals-receives-fda-fast-track-designation-for-kpi-012-a-human-msc-s-therapy-for-persistent-corneal-epithelial-defect/2481526/The FDA has granted Fast Track designation for Kala Pharmaceuticals' human mesenchymal stem cell secretome (MSC-S) therapy (KPI-012) for the treatment of persistent corneal epithelial defect (PCED). “There is a significant unmet need for patients suffering from PCED, whic
- Pfizer, BioNTech’s COVID-19 Vaccine Bags Full FDA Approvalhttps://modernod.com/news/pfizer-biontechs-covid-19-vaccine-bags-full-fda-approval/2479467/The FDA on Monday approved Pfizer and BioNTech’s BNT162b2, now known in the US as Comirnaty, to prevent COVID-19 in people ages 16 years and older, making it the first coronavirus vaccine to have its emergency-use authorization (EUA) converted into a full approval. “While millions of
- Pfizer, BioNTech’s COVID-19 Vaccine on Brink of Full FDA Approvalhttps://modernod.com/news/pfizer-biontechs-covid-19-vaccine-on-brink-of-full-fda-approval/2479464/According to people familiar with the matter, the FDA is expected to grant full approval to Pfizer and BioNTech’s COVID-19 vaccine BNT162b2 as soon as Monday, The New York Times reported. The sources suggested that the agency was aiming to complete the process by August 20, but was still wo
- Oertli’s CataRhex 3 Device Now Equipped With Speep Pump Innovationhttps://modernod.com/news/oertlis-catarhex-3-device-now-equipped-with-speep-pump-innovation/2479420/Oertli Instrumente has expanded the CataRhex 3 to include the pump innovation, “SPEEP,” which is designed to provide more efficiency and precision in cataract surgery due to precise control of flow and vacuum. The CataRhex 3 is Oertli’s compact and portable surgical platf